Andrew S. Runting

Andrew S. Runting

Auto-generated profile, based on publicly available information

Andrew S. Runting

Melbourne Tumor Biology Branch, Ludwig Institute for Cancer Research, Royal Melbourne Hospital, Victoria, Australia

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2007 in Growth Factors
Verified
Journal Article
Closed access
RSRamin Shayan
Ramin Shayan
TKTara Karnezis
Tara Karnezis
ETEvelyn Tsantikos
Evelyn Tsantikos
SWSteven P. Williams
Steven P. Williams
ARAndrew S. Runting
Andrew S. Runting
Steven StackerSteven Stacker
Steven Stacker
The lymphatic vasculature is critical for immunity and interstitial fluid homeostasis, playing important roles in diseases such as lymphedema and metastatic cancer. Animal models have been generated to explore the role of lymphatics and lymphangiogenic growth factors in such diseases, and to study lymphatic development. However, analysis of lymphatic vessels has primary been restricted to counting lymphatics in two-dimensional tissue slices, due to a lack of more sophisticated methodologies. In order to accurately examine lymphatic dysfunction in these models, and analyse the effects of lymphangiogenic growth factors on the lymphatic vasculature, it is essential to quantify the morphology and patterning of the distinct lymphatic vessels types in three-dimensional tissues. Here, we describe a method for performing such analyses, integrating user-operated image-analysis software with an approach that considers important morphological, anatomical and patterning features of the distinct lymphatic vessel subtypes. This efficient, reproducible technique is validated by analysing healthy and pathological tissues.

1 January 1993
Verified
Journal Article
Closed access
ARA S Runting
A S Runting
Steven StackerSteven Stacker
Steven Stacker
AWA F Wilks
A F Wilks

1 January 2000 in Growth Factors
Verified
Journal Article
Closed access
PDF file
Steven StackerSteven Stacker
Steven Stacker
ARA. S. Runting
A. S. Runting
CCC. Caesar
C. Caesar
AVA. Vitali
A. Vitali
MLM. Lackmann
M. Lackmann
AWA. F. Wilks
A. F. Wilks
The tie2 receptor tyrosine kinase plays a key role in angiogenesis, and the remodeling and maturation of blood vessels. In this study we have used a factor-dependent cell line (Ba/F3) expressing a chimeric receptor containing the extracellular domain of mouse tie2 and the transmembrane and cytoplasmic domain of the erythropoietin receptor to identify specific binding activity associated with an adipogenic sub-line of 3T3 fibroblasts (3T3-L1). 3T3-L1 fibroblasts are capable of undergoing differentiation to adipocytes under specific culture conditions. When compared to 3T3-L1 cells, the adipocyte differentiated cultures, which contain both pre-adipocytes and adipocytes, exhibited a significantly increased ability to support the growth of Ba/F3 cells expressing the chimeric receptor. Using probes specific for two recently described ligands for tie2, Ang-1 and Ang-2, we have shown that mRNA encoding Ang-1 is upregulated when 3T3-L1 fibroblasts are differentiated to adipocytes. These results suggest that the levels of Ang-1 protein and mRNA in 3T3-L1 cells can be regulated by cellular differentiation in adipose development.

1 April 1997 in International Journal of Peptide Research and Therapeutics
Verified
Journal Article
Closed access
PDF file
ENEdouard Nice
Edouard Nice
BCBruno Catimel
Bruno Catimel
MLMartin Lackmann
Martin Lackmann
Steven StackerSteven Stacker
Steven Stacker
ARAndrew Runting
Andrew Runting
Antony W BurgessAntony W Burgess
Antony W Burgess

1 January 1992
Verified
Book Chapter
Closed access
PDF file
MGMark Guthridge
Mark Guthridge
JSJacqueline Schmitt
Jacqueline Schmitt
JBJoseph Bertolini
Joseph Bertolini
JCJane Cowling
Jane Cowling
ARAndrew Runting
Andrew Runting
MHMilton T. W. Hearn
Milton T. W. Hearn